PharmaCyte Biotech Inc (PMCB)

[ace1234]

I am a hard long, but brace yourselves:



Based on advice from our consulting oncologists, our Chief Medical Officer and our Advisory Board regarding our planned trial design, we have determined that the data contained in previous clinical trial reports are not enough to fully support a Phase 3 pivotal trial and therefore we are designing a Phase 2b clinical trial that, if successful, we believe will provide the information necessary for a successful Phase 3 pivotal trial. Therefore, our determination to first conduct a Phase 2b clinical trial before conducting a pivotal Phase 3 trial will likely result in additional costs to us and resultant delays in the regulatory review process and any future commercialization and marketing, if regulatory approval is obtained.


May be a while longer before anything happens. If/when IND is submitted will tell us a lot, but right now it's unknown.

Regarding share price dilution from the offering it's 0.05 a share? Anyone with some decent experience explain that part to me?